Literature DB >> 15807148

Nonparametric methods for analysing the accuracy of diagnostic tests with multiple readers.

Jörg Kaufmann1, Carola Werner, Edgar Brunner.   

Abstract

The evaluation of diagnostic agents or imaging procedures is governed by the same scientific and regulatory rules as that of other medical products. Receiver operating characteristic (ROC) curves, and especially the area under these ROC curves, are indices for the accuracy of a diagnostic test for continuous as well as ordinal data. The methodology of multivariate rank statistics for the nonparametric Behrens-Fisher problem is used to evaluate the accuracy of a diagnostic test in a complex factorial design with repeated measurements. Hypotheses are formulated by means of relative treatment effects and are tested by a multivariate extension of the Mann-Whitney statistic in a heteroscedastic model. The application of this method is demonstrated by the analysis of a data set from a diagnostic clinical trial.

Mesh:

Substances:

Year:  2005        PMID: 15807148     DOI: 10.1191/0962280205sm392oa

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  3 in total

1.  A wild bootstrap approach for the selection of biomarkers in early diagnostic trials.

Authors:  Antonia Zapf; Edgar Brunner; Frank Konietschke
Journal:  BMC Med Res Methodol       Date:  2015-05-01       Impact factor: 4.615

2.  Analysis of Predictive Values Based on Individual Risk Factors in Multi-Modality Trials.

Authors:  Katharina Lange; Edgar Brunner
Journal:  Diagnostics (Basel)       Date:  2013-03-15

3.  Diagnostic performance of PI-RADS version 2.1 compared to version 2.0 for detection of peripheral and transition zone prostate cancer.

Authors:  Madhuri Monique Rudolph; Alexander Daniel Jacques Baur; Hannes Cash; Matthias Haas; Samy Mahjoub; Alexander Hartenstein; Charlie Alexander Hamm; Nick Lasse Beetz; Frank Konietschke; Bernd Hamm; Patrick Asbach; Tobias Penzkofer
Journal:  Sci Rep       Date:  2020-09-29       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.